There's a strong case that healthcare is the most important sector in the stock market. Investors stand to benefit as ...

Novo Nordisk continues to expand its partnerships with telehealth companies to broaden access to its blockbuster weight loss ...

Novo Nordisk said on Thursday it will collaborate with WeightWatchers to sell its blockbuster weight-loss drug, Wegovy, ...

Investing.com -- LifeMD Inc (NASDAQ: LFMD) stock rose 4.3% following Novo Nordisk’s (NYSE: NVO) announcement that it will continue its collaboration with the telehealth provider to offer patients ...

Novo Nordisk announces collaboration with WeightWatchers to offer patients living with obesity access to FDA-approved Wegovy® ...

LifeMD is a fast-growing, profitable telehealth company with strong partnerships. Click here to read why LFMD stock is a Buy.

Compounded weight loss drugs have been mostly off the market for about a month, but the weight loss drug industry remains as unsettled as ever.

A unique business structure gives LifeMD access to the growing GLP-1 marketplace that can help boost the heavily shorted ...

With the business potentially at an important milestone, we thought we'd take a closer look at LifeMD, Inc.'s (NASDAQ:LFMD) future prospects. LifeMD, Inc. operates as a direct-to-patient telehealth ...

Teladoc (TDOC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...

Novo Nordisk said Monday it will end its collaboration with Hims & Hers that offered the weight loss medication Wegovy for ...

NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend ...